
DNA Analytics leverages artificial intelligence to enhance gene therapies, vaccines, and diagnostics, focusing on improving gene probe match strength through patent-pending algorithms. Their flagship product, Accu Match™, addresses the unmet medical needs in treating cancer, neurological, hepatological, retinal diseases, and rare genetic disorders. With a unique approach that improves match strength algorithms significantly, DNA Analytics positions itself as a leader in the biotechnology sector, aiming to reduce development time and costs for life-saving products. The company offers a customizable solution for scientists, ensuring confidentiality and support for seamless integration into existing systems.

DNA Analytics leverages artificial intelligence to enhance gene therapies, vaccines, and diagnostics, focusing on improving gene probe match strength through patent-pending algorithms. Their flagship product, Accu Match™, addresses the unmet medical needs in treating cancer, neurological, hepatological, retinal diseases, and rare genetic disorders. With a unique approach that improves match strength algorithms significantly, DNA Analytics positions itself as a leader in the biotechnology sector, aiming to reduce development time and costs for life-saving products. The company offers a customizable solution for scientists, ensuring confidentiality and support for seamless integration into existing systems.